aluates Reports

$ 0.0

Automative

Global Migraine Headache Drugs Market Research Report 2025

Published Date: July 2025

Report Code: QYRE-Auto-1A2265

Global Migraine Headache Drugs Market Insights Forecast to 2028

BUY CHAPTERS

Global Migraine Headache Drugs Market Research Report 2025

Code: QYRE-Auto-1A2265

Report

July 2025

Pages:93

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Pfizer Inc

Novartis

Johnson & Johnson

GSK

Merck

Eli Lilly

TEVA

Astrazeneca plc

Sun Pharma

Grunenthal

Endo Pharmaceuticals

Mylan NV

Bayer

Amneal Pharmaceuticals

Apotex

Ajanta Pharma

Allergan plc

Migraine Headache Drugs Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Migraine Headache Drugs Market

The global market for Migraine Headache Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Migraine treatment usually is with over-the-counter (OTC) migraine medication or prescription drugs.

Migraines, this type of headache often involves only one side of the head, but in some cases, patients may have pain bilaterally or on both sides. Migraine headache is a result of specific changes within the brain. It causes severe head pain that is often accompanied by sensitivity to light, sound, or smells.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Migraine Headache Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Migraine Headache Drugs.

The Migraine Headache Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Migraine Headache Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Migraine Headache Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Migraine Headache Drugs Market Report

Report Metric	Details
Report Name	Migraine Headache Drugs Market
CAGR	5%
Segment by Type	Almotriptan Eletriptan Sumatriptan Rizatriptan Zolmitriptan Naratriptan Frovatriptan Others
Segment by Application	Acute Migraine Common Migraine Classic Migraine Chronic Migraine Other Migraines
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer, Novartis, Johnson & Johnson, GSK, Merck, Eli Lilly, Teva, AstraZeneca, Sun Pharma, Grunenthal, Endo Pharmaceuticals, Mylan, Bayer, Amneal Pharmaceuticals, Apotex, Ajanta Pharma, Allergan
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Migraine Headache Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Migraine Headache Drugs Market report?

Ans: The main players in the Migraine Headache Drugs Market are Pfizer, Novartis, Johnson & Johnson, GSK, Merck, Eli Lilly, Teva, AstraZeneca, Sun Pharma, Grunenthal, Endo Pharmaceuticals, Mylan, Bayer, Amneal Pharmaceuticals, Apotex, Ajanta Pharma, Allergan

What are the Application segmentation covered in the Migraine Headache Drugs Market report?

Ans: The Applications covered in the Migraine Headache Drugs Market report are Acute Migraine, Common Migraine, Classic Migraine, Chronic Migraine, Other Migraines

What are the Type segmentation covered in the Migraine Headache Drugs Market report?

Ans: The Types covered in the Migraine Headache Drugs Market report are Almotriptan, Eletriptan, Sumatriptan, Rizatriptan, Zolmitriptan, Naratriptan, Frovatriptan, Others

Recommended Reports

Pain Management Drugs

Migraine & Headache

CNS & Psychiatric Drugs

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Migraine Headache Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Almotriptan

1.2.3 Eletriptan

1.2.4 Sumatriptan

1.2.5 Rizatriptan

1.2.6 Zolmitriptan

1.2.7 Naratriptan

1.2.8 Frovatriptan

1.2.9 Others

1.3 Market by Application

1.3.1 Global Migraine Headache Drugs Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Acute Migraine

1.3.3 Common Migraine

1.3.4 Classic Migraine

1.3.5 Chronic Migraine

1.3.6 Other Migraines

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Migraine Headache Drugs Market Perspective (2020-2031)

2.2 Global Migraine Headache Drugs Growth Trends by Region

2.2.1 Global Migraine Headache Drugs Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Migraine Headache Drugs Historic Market Size by Region (2020-2025)

2.2.3 Migraine Headache Drugs Forecasted Market Size by Region (2026-2031)

2.3 Migraine Headache Drugs Market Dynamics

2.3.1 Migraine Headache Drugs Industry Trends

2.3.2 Migraine Headache Drugs Market Drivers

2.3.3 Migraine Headache Drugs Market Challenges

2.3.4 Migraine Headache Drugs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Migraine Headache Drugs Players by Revenue

3.1.1 Global Top Migraine Headache Drugs Players by Revenue (2020-2025)

3.1.2 Global Migraine Headache Drugs Revenue Market Share by Players (2020-2025)

3.2 Global Migraine Headache Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Migraine Headache Drugs Revenue

3.4 Global Migraine Headache Drugs Market Concentration Ratio

3.4.1 Global Migraine Headache Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Migraine Headache Drugs Revenue in 2024

3.5 Global Key Players of Migraine Headache Drugs Head office and Area Served

3.6 Global Key Players of Migraine Headache Drugs, Product and Application

3.7 Global Key Players of Migraine Headache Drugs, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Migraine Headache Drugs Breakdown Data by Type

4.1 Global Migraine Headache Drugs Historic Market Size by Type (2020-2025)

4.2 Global Migraine Headache Drugs Forecasted Market Size by Type (2026-2031)

5 Migraine Headache Drugs Breakdown Data by Application

5.1 Global Migraine Headache Drugs Historic Market Size by Application (2020-2025)

5.2 Global Migraine Headache Drugs Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Migraine Headache Drugs Market Size (2020-2031)

6.2 North America Migraine Headache Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Migraine Headache Drugs Market Size by Country (2020-2025)

6.4 North America Migraine Headache Drugs Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Migraine Headache Drugs Market Size (2020-2031)

7.2 Europe Migraine Headache Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Migraine Headache Drugs Market Size by Country (2020-2025)

7.4 Europe Migraine Headache Drugs Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Migraine Headache Drugs Market Size (2020-2031)

8.2 Asia-Pacific Migraine Headache Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Migraine Headache Drugs Market Size by Region (2020-2025)

8.4 Asia-Pacific Migraine Headache Drugs Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Migraine Headache Drugs Market Size (2020-2031)

9.2 Latin America Migraine Headache Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Migraine Headache Drugs Market Size by Country (2020-2025)

9.4 Latin America Migraine Headache Drugs Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Migraine Headache Drugs Market Size (2020-2031)

10.2 Middle East & Africa Migraine Headache Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Migraine Headache Drugs Market Size by Country (2020-2025)

10.4 Middle East & Africa Migraine Headache Drugs Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Pfizer

11.1.1 Pfizer Company Details

11.1.2 Pfizer Business Overview

11.1.3 Pfizer Migraine Headache Drugs Introduction

11.1.4 Pfizer Revenue in Migraine Headache Drugs Business (2020-2025)

11.1.5 Pfizer Recent Development

11.2 Novartis

11.2.1 Novartis Company Details

11.2.2 Novartis Business Overview

11.2.3 Novartis Migraine Headache Drugs Introduction

11.2.4 Novartis Revenue in Migraine Headache Drugs Business (2020-2025)

11.2.5 Novartis Recent Development

11.3 Johnson & Johnson

11.3.1 Johnson & Johnson Company Details

11.3.2 Johnson & Johnson Business Overview

11.3.3 Johnson & Johnson Migraine Headache Drugs Introduction

11.3.4 Johnson & Johnson Revenue in Migraine Headache Drugs Business (2020-2025)

11.3.5 Johnson & Johnson Recent Development

11.4 GSK

11.4.1 GSK Company Details

11.4.2 GSK Business Overview

11.4.3 GSK Migraine Headache Drugs Introduction

11.4.4 GSK Revenue in Migraine Headache Drugs Business (2020-2025)

11.4.5 GSK Recent Development

11.5 Merck

11.5.1 Merck Company Details

11.5.2 Merck Business Overview

11.5.3 Merck Migraine Headache Drugs Introduction

11.5.4 Merck Revenue in Migraine Headache Drugs Business (2020-2025)

11.5.5 Merck Recent Development

11.6 Eli Lilly

11.6.1 Eli Lilly Company Details

11.6.2 Eli Lilly Business Overview

11.6.3 Eli Lilly Migraine Headache Drugs Introduction

11.6.4 Eli Lilly Revenue in Migraine Headache Drugs Business (2020-2025)

11.6.5 Eli Lilly Recent Development

11.7 Teva

11.7.1 Teva Company Details

11.7.2 Teva Business Overview

11.7.3 Teva Migraine Headache Drugs Introduction

11.7.4 Teva Revenue in Migraine Headache Drugs Business (2020-2025)

11.7.5 Teva Recent Development

11.8 AstraZeneca

11.8.1 AstraZeneca Company Details

11.8.2 AstraZeneca Business Overview

11.8.3 AstraZeneca Migraine Headache Drugs Introduction

11.8.4 AstraZeneca Revenue in Migraine Headache Drugs Business (2020-2025)

11.8.5 AstraZeneca Recent Development

11.9 Sun Pharma

11.9.1 Sun Pharma Company Details

11.9.2 Sun Pharma Business Overview

11.9.3 Sun Pharma Migraine Headache Drugs Introduction

11.9.4 Sun Pharma Revenue in Migraine Headache Drugs Business (2020-2025)

11.9.5 Sun Pharma Recent Development

11.10 Grunenthal

11.10.1 Grunenthal Company Details

11.10.2 Grunenthal Business Overview

11.10.3 Grunenthal Migraine Headache Drugs Introduction

11.10.4 Grunenthal Revenue in Migraine Headache Drugs Business (2020-2025)

11.10.5 Grunenthal Recent Development

11.11 Endo Pharmaceuticals

11.11.1 Endo Pharmaceuticals Company Details

11.11.2 Endo Pharmaceuticals Business Overview

11.11.3 Endo Pharmaceuticals Migraine Headache Drugs Introduction

11.11.4 Endo Pharmaceuticals Revenue in Migraine Headache Drugs Business (2020-2025)

11.11.5 Endo Pharmaceuticals Recent Development

11.12 Mylan

11.12.1 Mylan Company Details

11.12.2 Mylan Business Overview

11.12.3 Mylan Migraine Headache Drugs Introduction

11.12.4 Mylan Revenue in Migraine Headache Drugs Business (2020-2025)

11.12.5 Mylan Recent Development

11.13 Bayer

11.13.1 Bayer Company Details

11.13.2 Bayer Business Overview

11.13.3 Bayer Migraine Headache Drugs Introduction

11.13.4 Bayer Revenue in Migraine Headache Drugs Business (2020-2025)

11.13.5 Bayer Recent Development

11.14 Amneal Pharmaceuticals

11.14.1 Amneal Pharmaceuticals Company Details

11.14.2 Amneal Pharmaceuticals Business Overview

11.14.3 Amneal Pharmaceuticals Migraine Headache Drugs Introduction

11.14.4 Amneal Pharmaceuticals Revenue in Migraine Headache Drugs Business (2020-2025)

11.14.5 Amneal Pharmaceuticals Recent Development

11.15 Apotex

11.15.1 Apotex Company Details

11.15.2 Apotex Business Overview

11.15.3 Apotex Migraine Headache Drugs Introduction

11.15.4 Apotex Revenue in Migraine Headache Drugs Business (2020-2025)

11.15.5 Apotex Recent Development

11.16 Ajanta Pharma

11.16.1 Ajanta Pharma Company Details

11.16.2 Ajanta Pharma Business Overview

11.16.3 Ajanta Pharma Migraine Headache Drugs Introduction

11.16.4 Ajanta Pharma Revenue in Migraine Headache Drugs Business (2020-2025)

11.16.5 Ajanta Pharma Recent Development

11.17 Allergan

11.17.1 Allergan Company Details

11.17.2 Allergan Business Overview

11.17.3 Allergan Migraine Headache Drugs Introduction

11.17.4 Allergan Revenue in Migraine Headache Drugs Business (2020-2025)

11.17.5 Allergan Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Pfizer Inc

Novartis

Johnson & Johnson

GSK

Merck

Eli Lilly

TEVA

Astrazeneca plc

Sun Pharma

Grunenthal

Endo Pharmaceuticals

Mylan NV

Bayer

Amneal Pharmaceuticals

Apotex

Ajanta Pharma

Allergan plc

List of Tables

Table 1. Global Migraine Headache Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Almotriptan

Table 3. Key Players of Eletriptan

Table 4. Key Players of Sumatriptan

Table 5. Key Players of Rizatriptan

Table 6. Key Players of Zolmitriptan

Table 7. Key Players of Naratriptan

Table 8. Key Players of Frovatriptan

Table 9. Global Migraine Headache Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 10. Global Migraine Headache Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 11. Global Migraine Headache Drugs Market Size by Region (2020-2025) & (US$ Million)

Table 12. Global Migraine Headache Drugs Market Share by Region (2020-2025)

Table 13. Global Migraine Headache Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 14. Global Migraine Headache Drugs Market Share by Region (2026-2031)

Table 15. Migraine Headache Drugs Market Trends

Table 16. Migraine Headache Drugs Market Drivers

Table 17. Migraine Headache Drugs Market Challenges

Table 18. Migraine Headache Drugs Market Restraints

Table 19. Global Migraine Headache Drugs Revenue by Players (2020-2025) & (US$ Million)

Table 20. Global Migraine Headache Drugs Market Share by Players (2020-2025)

Table 21. Global Top Migraine Headache Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Migraine Headache Drugs as of 2024)

Table 22. Ranking of Global Top Migraine Headache Drugs Companies by Revenue (US$ Million) in 2024

Table 23. Global 5 Largest Players Market Share by Migraine Headache Drugs Revenue (CR5 and HHI) & (2020-2025)

Table 24. Global Key Players of Migraine Headache Drugs, Headquarters and Area Served

Table 25. Global Key Players of Migraine Headache Drugs, Product and Application

Table 26. Global Key Players of Migraine Headache Drugs, Date of Enter into This Industry

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Migraine Headache Drugs Market Size by Type (2020-2025) & (US$ Million)

Table 29. Global Migraine Headache Drugs Revenue Market Share by Type (2020-2025)

Table 30. Global Migraine Headache Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 31. Global Migraine Headache Drugs Revenue Market Share by Type (2026-2031)

Table 32. Global Migraine Headache Drugs Market Size by Application (2020-2025) & (US$ Million)

Table 33. Global Migraine Headache Drugs Revenue Market Share by Application (2020-2025)

Table 34. Global Migraine Headache Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 35. Global Migraine Headache Drugs Revenue Market Share by Application (2026-2031)

Table 36. North America Migraine Headache Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. North America Migraine Headache Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 38. North America Migraine Headache Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 39. Europe Migraine Headache Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 40. Europe Migraine Headache Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 41. Europe Migraine Headache Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 42. Asia-Pacific Migraine Headache Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 43. Asia-Pacific Migraine Headache Drugs Market Size by Region (2020-2025) & (US$ Million)

Table 44. Asia-Pacific Migraine Headache Drugs Market Size by Region (2026-2031) & (US$ Million)

Table 45. Latin America Migraine Headache Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Latin America Migraine Headache Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 47. Latin America Migraine Headache Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 48. Middle East & Africa Migraine Headache Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 49. Middle East & Africa Migraine Headache Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 50. Middle East & Africa Migraine Headache Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 51. Pfizer Company Details

Table 52. Pfizer Business Overview

Table 53. Pfizer Migraine Headache Drugs Product

Table 54. Pfizer Revenue in Migraine Headache Drugs Business (2020-2025) & (US$ Million)

Table 55. Pfizer Recent Development

Table 56. Novartis Company Details

Table 57. Novartis Business Overview

Table 58. Novartis Migraine Headache Drugs Product

Table 59. Novartis Revenue in Migraine Headache Drugs Business (2020-2025) & (US$ Million)

Table 60. Novartis Recent Development

Table 61. Johnson & Johnson Company Details

Table 62. Johnson & Johnson Business Overview

Table 63. Johnson & Johnson Migraine Headache Drugs Product

Table 64. Johnson & Johnson Revenue in Migraine Headache Drugs Business (2020-2025) & (US$ Million)

Table 65. Johnson & Johnson Recent Development

Table 66. GSK Company Details

Table 67. GSK Business Overview

Table 68. GSK Migraine Headache Drugs Product

Table 69. GSK Revenue in Migraine Headache Drugs Business (2020-2025) & (US$ Million)

Table 70. GSK Recent Development

Table 71. Merck Company Details

Table 72. Merck Business Overview

Table 73. Merck Migraine Headache Drugs Product

Table 74. Merck Revenue in Migraine Headache Drugs Business (2020-2025) & (US$ Million)

Table 75. Merck Recent Development

Table 76. Eli Lilly Company Details

Table 77. Eli Lilly Business Overview

Table 78. Eli Lilly Migraine Headache Drugs Product

Table 79. Eli Lilly Revenue in Migraine Headache Drugs Business (2020-2025) & (US$ Million)

Table 80. Eli Lilly Recent Development

Table 81. Teva Company Details

Table 82. Teva Business Overview

Table 83. Teva Migraine Headache Drugs Product

Table 84. Teva Revenue in Migraine Headache Drugs Business (2020-2025) & (US$ Million)

Table 85. Teva Recent Development

Table 86. AstraZeneca Company Details

Table 87. AstraZeneca Business Overview

Table 88. AstraZeneca Migraine Headache Drugs Product

Table 89. AstraZeneca Revenue in Migraine Headache Drugs Business (2020-2025) & (US$ Million)

Table 90. AstraZeneca Recent Development

Table 91. Sun Pharma Company Details

Table 92. Sun Pharma Business Overview

Table 93. Sun Pharma Migraine Headache Drugs Product

Table 94. Sun Pharma Revenue in Migraine Headache Drugs Business (2020-2025) & (US$ Million)

Table 95. Sun Pharma Recent Development

Table 96. Grunenthal Company Details

Table 97. Grunenthal Business Overview

Table 98. Grunenthal Migraine Headache Drugs Product

Table 99. Grunenthal Revenue in Migraine Headache Drugs Business (2020-2025) & (US$ Million)

Table 100. Grunenthal Recent Development

Table 101. Endo Pharmaceuticals Company Details

Table 102. Endo Pharmaceuticals Business Overview

Table 103. Endo Pharmaceuticals Migraine Headache Drugs Product

Table 104. Endo Pharmaceuticals Revenue in Migraine Headache Drugs Business (2020-2025) & (US$ Million)

Table 105. Endo Pharmaceuticals Recent Development

Table 106. Mylan Company Details

Table 107. Mylan Business Overview

Table 108. Mylan Migraine Headache Drugs Product

Table 109. Mylan Revenue in Migraine Headache Drugs Business (2020-2025) & (US$ Million)

Table 110. Mylan Recent Development

Table 111. Bayer Company Details

Table 112. Bayer Business Overview

Table 113. Bayer Migraine Headache Drugs Product

Table 114. Bayer Revenue in Migraine Headache Drugs Business (2020-2025) & (US$ Million)

Table 115. Bayer Recent Development

Table 116. Amneal Pharmaceuticals Company Details

Table 117. Amneal Pharmaceuticals Business Overview

Table 118. Amneal Pharmaceuticals Migraine Headache Drugs Product

Table 119. Amneal Pharmaceuticals Revenue in Migraine Headache Drugs Business (2020-2025) & (US$ Million)

Table 120. Amneal Pharmaceuticals Recent Development

Table 121. Apotex Company Details

Table 122. Apotex Business Overview

Table 123. Apotex Migraine Headache Drugs Product

Table 124. Apotex Revenue in Migraine Headache Drugs Business (2020-2025) & (US$ Million)

Table 125. Apotex Recent Development

Table 126. Ajanta Pharma Company Details

Table 127. Ajanta Pharma Business Overview

Table 128. Ajanta Pharma Migraine Headache Drugs Product

Table 129. Ajanta Pharma Revenue in Migraine Headache Drugs Business (2020-2025) & (US$ Million)

Table 130. Ajanta Pharma Recent Development

Table 131. Allergan Company Details

Table 132. Allergan Business Overview

Table 133. Allergan Migraine Headache Drugs Product

Table 134. Allergan Revenue in Migraine Headache Drugs Business (2020-2025) & (US$ Million)

Table 135. Allergan Recent Development

Table 136. Research Programs/Design for This Report

Table 137. Key Data Information from Secondary Sources

Table 138. Key Data Information from Primary Sources

Table 139. Authors List of This Report

List of Figures

Figure 1. Migraine Headache Drugs Picture

Figure 2. Global Migraine Headache Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Migraine Headache Drugs Market Share by Type: 2024 VS 2031

Figure 4. Almotriptan Features

Figure 5. Eletriptan Features

Figure 6. Sumatriptan Features

Figure 7. Rizatriptan Features

Figure 8. Zolmitriptan Features

Figure 9. Naratriptan Features

Figure 10. Frovatriptan Features

Figure 11. Others Features

Figure 12. Global Migraine Headache Drugs Market Size by Application (2020-2031) & (US$ Million)

Figure 13. Global Migraine Headache Drugs Market Share by Application: 2024 VS 2031

Figure 14. Acute Migraine Case Studies

Figure 15. Common Migraine Case Studies

Figure 16. Classic Migraine Case Studies

Figure 17. Chronic Migraine Case Studies

Figure 18. Other Migraines Case Studies

Figure 19. Migraine Headache Drugs Report Years Considered

Figure 20. Global Migraine Headache Drugs Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 21. Global Migraine Headache Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 22. Global Migraine Headache Drugs Market Share by Region: 2024 VS 2031

Figure 23. Global Migraine Headache Drugs Market Share by Players in 2024

Figure 24. Global Top Migraine Headache Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Migraine Headache Drugs as of 2024)

Figure 25. The Top 10 and 5 Players Market Share by Migraine Headache Drugs Revenue in 2024

Figure 26. North America Migraine Headache Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. North America Migraine Headache Drugs Market Share by Country (2020-2031)

Figure 28. United States Migraine Headache Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Canada Migraine Headache Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Europe Migraine Headache Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Europe Migraine Headache Drugs Market Share by Country (2020-2031)

Figure 32. Germany Migraine Headache Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. France Migraine Headache Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. U.K. Migraine Headache Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Italy Migraine Headache Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Russia Migraine Headache Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Nordic Countries Migraine Headache Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Asia-Pacific Migraine Headache Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Asia-Pacific Migraine Headache Drugs Market Share by Region (2020-2031)

Figure 40. China Migraine Headache Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Japan Migraine Headache Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. South Korea Migraine Headache Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Southeast Asia Migraine Headache Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. India Migraine Headache Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Australia Migraine Headache Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Latin America Migraine Headache Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Latin America Migraine Headache Drugs Market Share by Country (2020-2031)

Figure 48. Mexico Migraine Headache Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Brazil Migraine Headache Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Middle East & Africa Migraine Headache Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. Middle East & Africa Migraine Headache Drugs Market Share by Country (2020-2031)

Figure 52. Turkey Migraine Headache Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 53. Saudi Arabia Migraine Headache Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 54. UAE Migraine Headache Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 55. Pfizer Revenue Growth Rate in Migraine Headache Drugs Business (2020-2025)

Figure 56. Novartis Revenue Growth Rate in Migraine Headache Drugs Business (2020-2025)

Figure 57. Johnson & Johnson Revenue Growth Rate in Migraine Headache Drugs Business (2020-2025)

Figure 58. GSK Revenue Growth Rate in Migraine Headache Drugs Business (2020-2025)

Figure 59. Merck Revenue Growth Rate in Migraine Headache Drugs Business (2020-2025)

Figure 60. Eli Lilly Revenue Growth Rate in Migraine Headache Drugs Business (2020-2025)

Figure 61. Teva Revenue Growth Rate in Migraine Headache Drugs Business (2020-2025)

Figure 62. AstraZeneca Revenue Growth Rate in Migraine Headache Drugs Business (2020-2025)

Figure 63. Sun Pharma Revenue Growth Rate in Migraine Headache Drugs Business (2020-2025)

Figure 64. Grunenthal Revenue Growth Rate in Migraine Headache Drugs Business (2020-2025)

Figure 65. Endo Pharmaceuticals Revenue Growth Rate in Migraine Headache Drugs Business (2020-2025)

Figure 66. Mylan Revenue Growth Rate in Migraine Headache Drugs Business (2020-2025)

Figure 67. Bayer Revenue Growth Rate in Migraine Headache Drugs Business (2020-2025)

Figure 68. Amneal Pharmaceuticals Revenue Growth Rate in Migraine Headache Drugs Business (2020-2025)

Figure 69. Apotex Revenue Growth Rate in Migraine Headache Drugs Business (2020-2025)

Figure 70. Ajanta Pharma Revenue Growth Rate in Migraine Headache Drugs Business (2020-2025)

Figure 71. Allergan Revenue Growth Rate in Migraine Headache Drugs Business (2020-2025)

Figure 72. Bottom-up and Top-down Approaches for This Report

Figure 73. Data Triangulation

Figure 74. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Migraine Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

OTC Migraine Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

OTC Migraine Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Prescription Headache Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Prescription Migraine Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Prescription Migraine Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

OTC Headache Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Acute Migraine Medications Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Headache Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Acute Migraine Treatments Market Research Report 2024

Global Chronic Migraine Treatment Market Research Report 2024

Migraine Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Ocular Pain Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Digital Migraine Treatment Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Triptans for Migraine Headaches Market Research Report 2025

Global Migraine Drugs Market Research Report 2025

Global Headache Relief Wearable Device Market Research Report 2024

Global Electronic Aspirin Market Research Report 2024

Global CGRP Targeting Drugs for Migraine Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions